Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Cidofovir highlighted at retroviral conference

Jan. 30, 1997

Pilot trial of folic acid in stroke patients

Jan. 30, 1997

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Encouraging results reported for Merck anti-HIV combination

Jan. 30, 1997

Triple combination therapy dramatically effective in HIV/AIDS

Jan. 30, 1997

Doxil superior to other treatments for first-line treatment of Kaposi's sarcoma

Jan. 29, 1997

Combination HIV-IG/MAbs shows synergistic anti-HIV effects

Jan. 28, 1997

Preliminary results for potential new anti-HIV combination presented

Jan. 28, 1997

German investigators present potent dopamine D1 antagonist

Jan. 3, 1997

5-LO inhibitor under evaluation at SKB

Dec. 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026